Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). A detailed literature review was conducted on epidemiology, risk factors, pathophysiology, chemoprevention and outcomes of colorectal cancer (CRC) in IBD as part of the 3rd ECCO scientific pathogenesis workshop.
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I) / S. Sebastian, V. Hernández, P. Myrelid, R. Kariv, E. Tsianos, M. Toruner, M. Marti-Gallostra, A. Spinelli, A.E. van der Meulen-de Jong, E.S. Yuksel, C. Gasche, S. Ardizzone, S. Danese. - In: JOURNAL OF CROHN'S AND COLITIS. - ISSN 1873-9946. - 8:1(2014), pp. 5-18. [Epub ahead of print]
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)
A. Spinelli;S. Ardizzone;
2014
Abstract
Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). A detailed literature review was conducted on epidemiology, risk factors, pathophysiology, chemoprevention and outcomes of colorectal cancer (CRC) in IBD as part of the 3rd ECCO scientific pathogenesis workshop.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.